Return to search

OrbiMed and Third Rock lead Series A round for Terremoto Biosciences

Terremoto Biosciences, a biotechnology company, has raised $75 million in Series A financing.

Terremoto Biosciences, a biotechnology company, has raised $75 million in Series A financing. OrbiMed and Third Rock Ventures led the round.

Source: Press Release